Syngene International Limited (NSE:SYNGENE)
India · Delayed Price · Currency is INR 631.70
+8.85 (1.42%)
Oct 1, 2025, 3:30 PM IST
Syngene International Market Cap
Syngene International has a market cap or net worth of 251.41 billion as of October 2, 2025. Its market cap has decreased by -31.57% in one year.
Market Cap
251.41B
Enterprise Value
243.22B
Revenue
37.27B
Ranking
n/a
PE Ratio
53.08
Stock Price
631.70
Market Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 251.41B, an increase of 304.79%. That is a compound annual growth rate of 14.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 251.41B | -26.36% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | 253.62B | 100.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,813.26B |
| Divi's Laboratories | 1,512.51B |
| Cipla | 1,201.94B |
| Apollo Hospitals Enterprise | 1,070.33B |
| Mankind Pharma | 1,016.21B |
| Zydus Lifesciences | 998.28B |
| Fortis Healthcare | 732.88B |
| Alkem Laboratories | 646.73B |